Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 5
2006 2
2008 2
2009 1
2010 2
2012 1
2015 1
2016 2
2017 5
2018 4
2019 3
2020 4
2021 2
2022 2
2023 7
2024 4
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Autoimmune liver diseases and diabetes.
Jensen AH, Ytting H, Winther-Sørensen M, Burisch J, Bergquist A, Gluud LL, Wewer Albrechtsen NJ. Jensen AH, et al. Among authors: ytting h. Eur J Gastroenterol Hepatol. 2023 Sep 1;35(9):938-947. doi: 10.1097/MEG.0000000000002594. Epub 2023 Jun 22. Eur J Gastroenterol Hepatol. 2023. PMID: 37505973
Unmet needs in autoimmune hepatitis: Results of the prospective multicentre European Reference Network Registry (R-LIVER).
Schregel I, Papp M, Sipeki N, Kovats PJ, Taubert R, Engel B, Campos-Murguia A, Dalekos GN, Gatselis N, Zachou K, Milkiewicz P, Janik MK, Raszeja-Wyszomirska J, Ytting H, Braun F, Casar C, Sebode M, Lohse AW, Schramm C; European Reference Network (ERN) RARE‐LIVER. Schregel I, et al. Among authors: ytting h. Liver Int. 2024 Oct;44(10):2687-2699. doi: 10.1111/liv.16035. Epub 2024 Jul 22. Liver Int. 2024. PMID: 39037185
Patients with autoimmune liver disease have glucose disturbances that mechanistically differ from steatotic liver disease.
Jensen AH, Ytting H, Werge MP, Rashu EB, Hetland LE, Thing M, Nabilou P, Burisch J, Bojsen-Møller KN, Junker AE, Hobolth L, Mortensen C, Tofteng F, Bendtsen F, Møller S, Vyberg M, Serizawa RR, Gluud LL, Wewer Albrechtsen NJ. Jensen AH, et al. Among authors: ytting h. Am J Physiol Gastrointest Liver Physiol. 2024 Jun 1;326(6):G736-G746. doi: 10.1152/ajpgi.00047.2024. Epub 2024 Apr 16. Am J Physiol Gastrointest Liver Physiol. 2024. PMID: 38625142
Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases.
Lynch KD, Chapman RW, Keshav S, Montano-Loza AJ, Mason AL, Kremer AE, Vetter M, de Krijger M, Ponsioen CY, Trivedi P, Hirschfield G, Schramm C, Liu CH, Bowlus CL, Estes DJ, Pratt D, Hedin C, Bergquist A, de Vries AC, van der Woude CJ, Yu L, Assis DN, Boyer J, Ytting H, Hallibasic E, Trauner M, Marschall HU, Daretti LM, Marzioni M, Yimam KK, Perin N, Floreani A, Beretta-Piccoli BT, Rogers JK; International Primary Sclerosing Cholangitis Study Group (IPSCSG); Levy C. Lynch KD, et al. Among authors: ytting h. Clin Gastroenterol Hepatol. 2020 Jan;18(1):179-187.e6. doi: 10.1016/j.cgh.2019.05.013. Epub 2019 May 14. Clin Gastroenterol Hepatol. 2020. PMID: 31100458 Free PMC article.
Second-line and third-line therapy for autoimmune hepatitis: A position statement from the European Reference Network on Hepatological Diseases and the International Autoimmune Hepatitis Group.
Lohse AW, Sebode M, Jørgensen MH, Ytting H, Karlsen TH, Kelly D, Manns MP, Vesterhus M; European Reference Network on Hepatological Diseases (ERN RARE-LIVER); International Autoimmune Hepatitis Group (IAIHG). Lohse AW, et al. Among authors: ytting h. J Hepatol. 2020 Dec;73(6):1496-1506. doi: 10.1016/j.jhep.2020.07.023. Epub 2020 Jul 21. J Hepatol. 2020. PMID: 32707224 Review.
[Hepatitis after chewing of khat leaves].
Teisen E, Vainer B, Ytting H. Teisen E, et al. Among authors: ytting h. Ugeskr Laeger. 2016 May 16;178(20):V02160124. Ugeskr Laeger. 2016. PMID: 27189105 Free article. Danish.
41 results